Similar articles for PMID: 30648629

Year	Number of Results
1925	1
1933	1
1946	6
1949	1
1952	1
1987	1
2008	1
2011	2
2013	1
2014	1
2015	2
2016	13
2017	24
2018	43
2019	45
2020	25
2021	20
2022	13
2023	1
2024	0

1

State of clinical research of radiotherapy/chemoradiotherapy and immune checkpoint inhibitor therapy combinations in solid tumours-a German radiation oncology survey.

Käsmann L, Eze C, Dantes M, Roengvoraphoj O, Niyazi M, Belka C, Manapov F. Käsmann L, et al. Eur J Cancer. 2019 Feb;108:50-54. doi: 10.1016/j.ejca.2018.11.026. Epub 2019 Jan 12. Eur J Cancer. 2019. PMID: 30648629

2

Actualités et perspectives concernant l’immunothérapie en oncologie thoracique.

Mignard X, Chaabane N, Fallet V, Wislez M. Mignard X, et al. Bull Cancer. 2018 Dec;105 Suppl 1:S16-S23. doi: 10.1016/S0007-4551(18)30386-2. Bull Cancer. 2018. PMID: 30595194 Review. French.

3

Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma.

Choi C, Yoo GS, Cho WK, Park HC. Choi C, et al. World J Gastroenterol. 2019 May 28;25(20):2416-2429. doi: 10.3748/wjg.v25.i20.2416. World J Gastroenterol. 2019. PMID: 31171886 Free PMC article. Review.

4

Separating or combining immune checkpoint inhibitors (ICIs) and radiotherapy in the treatment of NSCLC brain metastases.

Li W, Yu H. Li W, et al. J Cancer Res Clin Oncol. 2020 Jan;146(1):137-152. doi: 10.1007/s00432-019-03094-9. Epub 2019 Dec 7. J Cancer Res Clin Oncol. 2020. PMID: 31813004 Review.

5

L’immunothérapie dans les cancers ORL.

Reverdy T, Gau M, Karabajakian A, Neidhardt EM, Fayette J. Reverdy T, et al. Bull Cancer. 2018 Dec;105 Suppl 1:S35-S42. doi: 10.1016/S0007-4551(18)30388-6. Bull Cancer. 2018. PMID: 30595197 Review. French.

6

Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG.

Knispel S, Stang A, Zimmer L, Lax H, Gutzmer R, Heinzerling L, Weishaupt C, Pföhler C, Gesierich A, Herbst R, Kaehler KC, Weide B, Berking C, Loquai C, Utikal J, Terheyden P, Kaatz M, Schlaak M, Kreuter A, Ulrich J, Mohr P, Dippel E, Livingstone E, Becker JC, Weichenthal M, Chorti E, Gronewold J, Schadendorf D, Ugurel S. Knispel S, et al. J Immunother Cancer. 2020 May;8(1):e000395. doi: 10.1136/jitc-2019-000395. J Immunother Cancer. 2020. PMID: 32371460 Free PMC article.

7

Current status of immune checkpoint inhibition in early-stage NSCLC.

Vansteenkiste J, Wauters E, Reymen B, Ackermann CJ, Peters S, De Ruysscher D. Vansteenkiste J, et al. Ann Oncol. 2019 Aug 1;30(8):1244-1253. doi: 10.1093/annonc/mdz175. Ann Oncol. 2019. PMID: 31143921 Free article. Review.

8

The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.

Mahoney KM, Freeman GJ, McDermott DF. Mahoney KM, et al. Clin Ther. 2015 Apr 1;37(4):764-82. doi: 10.1016/j.clinthera.2015.02.018. Epub 2015 Mar 29. Clin Ther. 2015. PMID: 25823918 Free PMC article. Review.

9

Interventional therapy combined with immune checkpoint inhibitors: Emerging opportunities for cancer treatment in the era of immunotherapy.

Chang X, Lu X, Guo J, Teng GJ. Chang X, et al. Cancer Treat Rev. 2019 Mar;74:49-60. doi: 10.1016/j.ctrv.2018.08.006. Epub 2018 Aug 20. Cancer Treat Rev. 2019. PMID: 30831375 Review.

10

Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer.

Hu ZI, Ho AY, McArthur HL. Hu ZI, et al. Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):153-164. doi: 10.1016/j.ijrobp.2017.05.029. Epub 2017 May 26. Int J Radiat Oncol Biol Phys. 2017. PMID: 28816141 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

180 results

Results by year